Cargando…
Letter to the editor: Wide indication for SARS-CoV-2-testing allowed identification of international risk areas during the early phase of the COVID-19 pandemic in Germany
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403636/ https://www.ncbi.nlm.nih.gov/pubmed/32553063 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.23.2001119 |
| _version_ | 1783566981296816128 |
|---|---|
| author | Rexroth, Ute Hamouda, Osamah Hanefeld, Johanna Ruehe, Bettina Wieler, Lothar H Schaade, Lars |
| author_facet | Rexroth, Ute Hamouda, Osamah Hanefeld, Johanna Ruehe, Bettina Wieler, Lothar H Schaade, Lars |
| author_sort | Rexroth, Ute |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7403636 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | European Centre for Disease Prevention and Control (ECDC) |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74036362020-08-17 Letter to the editor: Wide indication for SARS-CoV-2-testing allowed identification of international risk areas during the early phase of the COVID-19 pandemic in Germany Rexroth, Ute Hamouda, Osamah Hanefeld, Johanna Ruehe, Bettina Wieler, Lothar H Schaade, Lars Euro Surveill Letter European Centre for Disease Prevention and Control (ECDC) 2020-06-11 /pmc/articles/PMC7403636/ /pubmed/32553063 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.23.2001119 Text en This article is copyright of the authors or their affiliated institutions, 2020. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
| spellingShingle | Letter Rexroth, Ute Hamouda, Osamah Hanefeld, Johanna Ruehe, Bettina Wieler, Lothar H Schaade, Lars Letter to the editor: Wide indication for SARS-CoV-2-testing allowed identification of international risk areas during the early phase of the COVID-19 pandemic in Germany |
| title | Letter to the editor: Wide indication for SARS-CoV-2-testing allowed identification of international risk areas during the early phase of the COVID-19 pandemic in Germany |
| title_full | Letter to the editor: Wide indication for SARS-CoV-2-testing allowed identification of international risk areas during the early phase of the COVID-19 pandemic in Germany |
| title_fullStr | Letter to the editor: Wide indication for SARS-CoV-2-testing allowed identification of international risk areas during the early phase of the COVID-19 pandemic in Germany |
| title_full_unstemmed | Letter to the editor: Wide indication for SARS-CoV-2-testing allowed identification of international risk areas during the early phase of the COVID-19 pandemic in Germany |
| title_short | Letter to the editor: Wide indication for SARS-CoV-2-testing allowed identification of international risk areas during the early phase of the COVID-19 pandemic in Germany |
| title_sort | letter to the editor: wide indication for sars-cov-2-testing allowed identification of international risk areas during the early phase of the covid-19 pandemic in germany |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403636/ https://www.ncbi.nlm.nih.gov/pubmed/32553063 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.23.2001119 |
| work_keys_str_mv | AT rexrothute lettertotheeditorwideindicationforsarscov2testingallowedidentificationofinternationalriskareasduringtheearlyphaseofthecovid19pandemicingermany AT hamoudaosamah lettertotheeditorwideindicationforsarscov2testingallowedidentificationofinternationalriskareasduringtheearlyphaseofthecovid19pandemicingermany AT hanefeldjohanna lettertotheeditorwideindicationforsarscov2testingallowedidentificationofinternationalriskareasduringtheearlyphaseofthecovid19pandemicingermany AT ruehebettina lettertotheeditorwideindicationforsarscov2testingallowedidentificationofinternationalriskareasduringtheearlyphaseofthecovid19pandemicingermany AT wielerlotharh lettertotheeditorwideindicationforsarscov2testingallowedidentificationofinternationalriskareasduringtheearlyphaseofthecovid19pandemicingermany AT schaadelars lettertotheeditorwideindicationforsarscov2testingallowedidentificationofinternationalriskareasduringtheearlyphaseofthecovid19pandemicingermany |